GEMIXINE
EL KENDI DU MEDICAMENT
Identification
- Active ingredient (INN)
- GEMIFLOXACINE MESYLATE EXPRIME EN GEMIFLOXACINE
- Internal code
- 13 K 334
- Country of Origin
- Algeria
- Pharmaceutical form
- Film-coated Tablet
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/10
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
The treatment is used in: the infection of the convicted reeds.
The treatment of some cases of community-based pneumonia, and pneumonia caused by antibiotic bacteria such as pulmonary node.
Associated Conditions
The treatment may be associated with increased risk of infection in the heart systems (the length of QT-long increase in the normality of the electrocardiogram), so it must be used with caution in patients with heart system disorders or who are taking other treatments affecting the keu-te period.
The treatment may be associated with increased risk of particular muscle in older patients and liver, heart and lung transplants.
- Carefully used in patients with neurological delusion and pel (myasthenia grifvis), avoiding use of treatment in case of a disease history of the disease, may cause a problem of muscle weakness in those patients.
- Use of the drug with a neurological weakness.
Mechanism of Action
Gymphoxacin is a fluoroconylon antibiotic, which discourages important enzymes for bacteria'growth, namely DNA gyrase and topoisomerase Intravenous, and thus kills bacteria and resists infection.
Do you have questions on this subject? Ask Sina, artificial intelligence to answer all your medical questions, write your question here, Sina is preparing the answer to you.